Alta Fundamental Advisers’s Indivior Pharmaceuticals INDV Stock Holding History

Alta Fundamental Advisers’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.5M	Hold	409,529	–	–	4.7%	7
2025 Q4	$14.7M	Sell	409,529 -65,520	-14%	-$2M	6.62%	5
2025 Q3	$11.5M	Sell	475,049 -100,000	-17%	-$2.09M	4.89%	8
2025 Q2	$8.48M	Buy	575,049 +240,580	+72%	+$2.8M	4.34%	8
2025 Q1	$3.19M	Sell	334,469 -65,531	-16%	-$689K	2.05%	16
2024 Q4	$4.97M	Buy	400,000 +75,000	+23%	+$772K	1.49%	17
2024 Q3	$2.39M	Hold	325,000	–	–	0.69%	21
2024 Q2	$4.03M	Buy	325,000 +175,000	+117%	+$3.16M	1.28%	14
2024 Q1	$2.54M	Hold	150,000	–	–	0.96%	16
2023 Q4	$1.78M	Hold	150,000	–	–	0.8%	16
2023 Q3	$2.67M	Hold	150,000	–	–	1.27%	11
2023 Q2	$2.73M	Buy	+150,000	New	+$3.44M	1.33%	9

Other funds holding INDV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alta Fundamental Advisers's INDV Position: Q1 2026 in Review

Alta Fundamental Advisers held its Indivior Pharmaceuticals (INDV) position steady in Q1 2026 at 409,529 shares worth $12.5M. The position accounts for 4.7% of the portfolio, ranked #7.

Alta Fundamental Advisers first reported a position in INDV in Q2 2023 and has held it in 12 quarters since. The position peaked at $14.7M in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

Alta Fundamental Advisers held 409,529 shares of Indivior Pharmaceuticals worth $12.5M as of Q1 2026.
Alta Fundamental Advisers left its Indivior Pharmaceuticals share count unchanged in Q1 2026.
Indivior Pharmaceuticals made up 4.7% of Alta Fundamental Advisers's portfolio in Q1 2026, its #7 holding.
Alta Fundamental Advisers first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
Alta Fundamental Advisers's Indivior Pharmaceuticals position peaked at $14.7M in Q4 2025.
289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Alta Fundamental Advisers's 13F filing for Q1 2026, filed 5 May 2026.